Hyking Haley
Impact in
-
- Radiopharmaceutical Chemistry and Applications
- Medical Imaging Techniques and Applications
- Monoclonal and Polyclonal Antibodies Research
-
- Cancer Immunotherapy and Biomarkers
- Peptidase Inhibition and Analysis
- CAR-T cell therapy research
Papers in
- Oncology 3
- Peptidase Inhibition and Analysis 1
- Bone health and treatments 1
-
- Bone Metabolism and Diseases 1
- RNA Interference and Gene Delivery 1
- Co-authors
- Daniel Rubins (6 shared papers)Xiangjun Meng (5 shared papers)Paul McQuade (4 shared papers)Shu-An Lin (3 shared papers)Dinko González Trotter (3 shared papers)Philip S. Low (2 shared papers)Zhizhen Zeng (3 shared papers)Qingshou Chen (2 shared papers)
- Journals
- Molecular Imaging and Biology (3 papers)Molecular Pharmaceutics (2 papers)Vaccine (1 paper)Journal of Lipid Research (1 paper)Journal of Labelled Compounds and Radiopharmaceuticals (1 paper)
- Partner nations
- United StatesNetherlandsUnited Kingdom
In The Last Decade
Hyking Haley
9 papers receiving 130 citations
Peers
Comparison fields: 5 of 43
- Radiology, Nuclear Medicine and Imaging 70
- Oncology 59
- Immunology 19
- Pulmonary and Respiratory Medicine 23
- Genetics 6
Countries citing papers authored by Hyking Haley
This map shows the geographic impact of Hyking Haley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hyking Haley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hyking Haley more than expected).
Fields of papers citing papers by Hyking Haley
This network shows the impact of papers produced by Hyking Haley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hyking Haley. The network helps show where Hyking Haley may publish in the future.
Co-authors
The 25 scholars most cited alongside Hyking Haley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 35 | |
| 2 | 2020 | 28 | |
| 3 | 2017 | 27 | |
| 4 | 2020 | 19 | |
| 5 | 2010 | 12 | |
| 6 | 2023 | 5 | |
| 7 | 2025 | 2 | |
| 8 | 2020 | 1 | |
| 9 | Investigation into Use of Positron Emission Tomography (PET) as an In Vivo Imaging Tool to Quantify PD-L1 Tumor Expression Levels | 2016 | 1 |
About Hyking Haley
Hyking Haley is a scholar working on Oncology, Molecular Biology, Immunology, Organic Chemistry and Pulmonary and Respiratory Medicine, having authored 9 papers that have together received 130 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (2 papers), Click Chemistry and Applications (1 paper), Inhalation and Respiratory Drug Delivery (1 paper), Bone Metabolism and Diseases (1 paper), Peptidase Inhibition and Analysis (1 paper), RNA Interference and Gene Delivery (1 paper), Advanced Drug Delivery Systems (1 paper) and Bone health and treatments (1 paper). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (70 citations), Oncology (59 citations), Immunology (19 citations), Pulmonary and Respiratory Medicine (23 citations) and Genetics (6 citations). Hyking Haley has collaborated with scholars based in United States, Netherlands and United Kingdom. Frequent co-authors include Daniel Rubins, Xiangjun Meng, Paul McQuade, Shu-An Lin, Dinko González Trotter, Philip S. Low, Zhizhen Zeng, Qingshou Chen, Mona Purcell and Michael Klimas. Their work appears in journals such as Molecular Imaging and Biology, Molecular Pharmaceutics, Vaccine, Journal of Lipid Research and Journal of Labelled Compounds and Radiopharmaceuticals.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.